Maxim Group Analysts Give Atossa Genetics (ATOS) a $10.00 Price Target

Maxim Group set a $10.00 price objective on Atossa Genetics (NASDAQ:ATOS) in a report released on Monday morning. The brokerage currently has a buy rating on the stock.

Separately, ValuEngine raised shares of Atossa Genetics from a sell rating to a hold rating in a report on Wednesday, May 2nd.

ATOS stock opened at $3.73 on Monday. Atossa Genetics has a fifty-two week low of $3.86 and a fifty-two week high of $3.86.

Atossa Genetics (NASDAQ:ATOS) last posted its quarterly earnings data on Monday, May 14th. The company reported ($0.71) earnings per share for the quarter, topping the consensus estimate of ($0.86) by $0.15. analysts expect that Atossa Genetics will post -4.68 EPS for the current fiscal year.

Atossa Genetics Company Profile

Atossa Genetics Inc a clinical-stage pharmaceutical company, focuses on the development and sale of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions in the United States. The company is conducting a Phase 2 clinical study using microcatheters to deliver fulvestrant as a potential treatment of ductal carcinoma in situ and breast cancer; and a pharmaceutical program under development is Endoxifen, an active metabolite of tamoxifen, as well as treatment for breast density and other breast health conditions.

Receive News & Ratings for Atossa Genetics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atossa Genetics and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Mackay Shields LLC Acquires Shares of 30,300 LSC Communications
Mackay Shields LLC Acquires Shares of 30,300 LSC Communications
Mackay Shields LLC Invests $553,000 in Range Resources Corp.
Mackay Shields LLC Invests $553,000 in Range Resources Corp.
50,700 Shares in Immersion Co.  Purchased by Mackay Shields LLC
50,700 Shares in Immersion Co. Purchased by Mackay Shields LLC
SG Americas Securities LLC Takes $952,000 Position in Core-Mark Holding Company, Inc.
SG Americas Securities LLC Takes $952,000 Position in Core-Mark Holding Company, Inc.
Schlumberger Limited.  Position Boosted by Zeke Capital Advisors LLC
Schlumberger Limited. Position Boosted by Zeke Capital Advisors LLC
Aecon Group’s  “Outperform Overweight” Rating Reiterated at National Bank Financial
Aecon Group’s “Outperform Overweight” Rating Reiterated at National Bank Financial


Leave a Reply

 
© 2006-2018 Zolmax.